| Financial Year |
March 31 2023 |
| Monetary Funds |
154,863,648.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,154,029.16 |
| Accounts Receivable |
113,198,399.86 |
| Advances to Suppliers |
2,078,459.60 |
| Other Receivables |
1,733,287.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,711,473.24 |
| Dividend Receivable |
-- |
| Inventories |
65,319,659.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,286,552.24 |
| Total Current Assets |
363,195,105.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
30,937,648.14 |
| Fixed Assetes |
292,430,425.48 |
| Under-construction Projects |
38,818,232.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,240,718.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,505,247.87 |
| Other Non-Current Assets |
841,344.68 |
| Sub-Total of Non-Current Assets |
402,085,736.23 |
| Total Assets |
765,280,842.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,309,370.00 |
| Accounts Payable |
42,029,346.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,455,758.58 |
| Taxes Payable |
2,286,253.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,889,101.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
10,892,342.38 |
| Sub-Total of Current Liabilities |
86,725,125.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,600,906.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,226,861.39 |
| Total Liabilities |
104,951,986.72 |
| Paid-In Capital(Or Share Stock) |
102,775,000.00 |
| Capital Surplus |
244,306,559.09 |
| Surplus Reserve |
38,005,887.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
275,444,177.67 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
660,328,855.32 |
| Owner's Equity（Stockholder's Equity） |
660,328,855.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
765,280,842.04 |
